Jagsonpal Pharmaceuticals Limited has informed the Exchange about Schedule of meet
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has scheduled a conference call with analysts and investors on Monday, July 28, 2025, at 3:00 PM IST. The call will focus on discussing the company's Q1 FY26 financial results. The session is being hosted by Go India Advisors, with Managing Director Manish Gupta listed among the company participants. The announcement was made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). Interested participants can pre-register via a Diamond Pass link or dial in using the provided numbers.
This is a routine investor engagement activity ahead of the Q1 FY26 earnings, giving retail investors an opportunity to hear management discuss results. Conference calls themselves typically do not move the stock price, but any forward-looking guidance shared during the call could influence sentiment.